These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 231337)

  • 41. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
    Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
    Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of growth hormone and insulin upon MLC responses and the generation of cytotoxic lymphocytes.
    Snow EC; Feldbush TL; Oaks JA
    J Immunol; 1981 Jan; 126(1):161-4. PubMed ID: 6450234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The response of human T lymphocytes against alloantigens following Fas-mediated activation-induced cell death.
    Fujiwara T; Fujita H; Muranaka S; Utsumi K; Kusaka S; Hamazaki K
    Transplant Proc; 2005; 37(1):46-8. PubMed ID: 15808542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression.
    López-Botet M; Silva A; Rodríguez J; de Landazuri MO
    J Immunol; 1982 Sep; 129(3):1109-15. PubMed ID: 6213707
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of T cell-mediated functions by MVM(i), a parvovirus closely related to minute virus of mice.
    Engers HD; Louis JA; Zubler RH; Hirt B
    J Immunol; 1981 Dec; 127(6):2280-5. PubMed ID: 6457871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells.
    Gillis S; Crabtree GR; Smith KA
    J Immunol; 1979 Oct; 123(4):1632-8. PubMed ID: 158054
    [No Abstract]   [Full Text] [Related]  

  • 48. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.
    Farrar WL; Johnson HM; Farrar JJ
    J Immunol; 1981 Mar; 126(3):1120-5. PubMed ID: 6161959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
    J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mechanism of lymphocyte activation by periodic acids. Blastogenesis and induction of immunomodulator populations].
    Agneray J; Feger J; Durand G; Guenounou M; Danois D; Banchereau J
    C R Seances Soc Biol Fil; 1979; 173(2):247-60. PubMed ID: 228811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proliferative and cytotoxic capacities of human cultured T cells.
    Schendel DJ; Bonnard GD; Wank R; Dupont B
    Transplant Proc; 1978 Dec; 10(4):933-5. PubMed ID: 153619
    [No Abstract]   [Full Text] [Related]  

  • 53. Stimulation in primary and secondary MLC: comparison between normal lymphocytes and T and B lymphoblast cell lines before and after glutaraldehyde treatment.
    Brown JM; Kong YM; Peterson WD; Frost P; Kaplan J; Lightbody JJ
    Transplant Proc; 1976 Sep; 8(3):437-40. PubMed ID: 136075
    [No Abstract]   [Full Text] [Related]  

  • 54. Alloantigen-activated CML suppression independent of cytotoxic activity.
    Orosz CG; Bach FH
    J Immunol; 1979 Sep; 123(3):1419-21. PubMed ID: 157373
    [No Abstract]   [Full Text] [Related]  

  • 55. Biological effects of activation of human peripheral blood mononuclear cells by mitogenic oxidizing agents. I Alloantigen-independent activation of alloimmune memory cells.
    Suthanthiran M; Rubin AL; Novogrodsky A; Stenzel KH
    Cell Immunol; 1981 Mar; 59(1):26-41. PubMed ID: 6260389
    [No Abstract]   [Full Text] [Related]  

  • 56. Allo-antigen specific lymphocyte growth in vitro [proceedings].
    Antczak DF; Howard JC
    J Physiol; 1978 Nov; 284():6P-7P. PubMed ID: 83361
    [No Abstract]   [Full Text] [Related]  

  • 57. Monkey antiserum to MLC-primed human T lymphocytes.
    Singal DP
    Transplant Proc; 1979 Jun; 11(2):1329-30. PubMed ID: 89737
    [No Abstract]   [Full Text] [Related]  

  • 58. Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents.
    Suthanthiran M; Rubin AL; Novogrodsky A; Stenzel KH
    Transplantation; 1980 Oct; 30(4):269-74. PubMed ID: 6255637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic specificity of primary and secondary proliferative and cytotoxic responses of human lymphocytes grown in continued culture.
    Schendel DJ; Wank R; Bonnard GD
    Scand J Immunol; 1980; 11(1):99-107. PubMed ID: 9537035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Periodate-induced lymphocyte transformation. VI. Stimulation of human lymphocytes by periodate-treated allogeneic cells.
    Parker JW; Dixon JF; O'Brien RL
    Exp Cell Res; 1977 Jun; 107(1):169-77. PubMed ID: 193705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.